EXCELSIOR, MN – August 17, 2020 – INNOVATION PARTNERS LLC today announced the appointment of Kimberly Drager as Director, Business Development.

Kimberly comes to Innovation Partners with 10+ years of leadership experience with hematology and oncology focused organizations. Her leadership focus included business development, fundraising and program management. Kimberly is highly skilled at developing and cultivating meaningful relationships and will lead Innovation Partners business development and marketing efforts.

Kimberly’s previous roles included management of the business development team at the National Comprehensive Cancer Network (NCCN) and the development roles with the American Cancer Society. She holds a finance degree from the Penn State University Smeal College of Business.

Kimberly joins Dave Melin, Founder and Managing Director, and the following recent team additions:

Matthew Steele, Senior Manager, Market Research and Client Analytics, joined June 2020.

  • Significant experience in applied research and data analysis in a variety of roles across the non-profit and private sectors. Master’s in Public Policy and background in government affairs at the Minnesota Senate.

Holly Ponder, Director, Human Resources and Corporate Planning, joined January 2020.

  • 10+ years experience in Human Resources, project management and administration. Recent position at Loxo Oncology working with multiple teams including HR, Medical Affairs and Finance. Law degree and pursing Master’s in Management.

Jenna Roberts, Director, Market Research and Client Analytics, joined December 2017.

  • Strong background in market research, data and analytics and project management within the healthcare industry. Most recent positions at Magellan Medical Technology Consultants and McKesson.


Innovation Partners, LLC (IP) is a growing, agile and high-touch biomedical consulting company that partners with U.S. and global manufacturers to bring their drug, devices and other healthcare innovations to a successful U.S. market launch and commercialization. IP is focused on collaborating with biopharmaceutical, medical device/technology, and molecular diagnostic manufacturers to make their innovations accessible to patients, providers, and payer stakeholders. Client roster includes innovators in oncology, hematology, neurology, infectious disease, and rare diseases. Core services and capabilities include medical affairs and education, market and payer access, market research and analytics. IP has partnered with clients to support over 20 hematology and oncology brand development and launch strategies since 2015. https://innovationpartners.org/

Dave Melin
Founder and Managing Director